A dynamic search mechanism enables APE1 to identify AP-sites in DNA
Nucleic Acids Research · 20.05.2026 · 54 (10)
DOI: 10.1093/nar/gkag523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 30.05.2026. Verfasst von Kaitlin M DeHart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United St…. Hauptthemen laut MEDLINE: DNA-(Apurinic or Apyrimidinic Site) Lyase, DNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIEHS NIH HHS, NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Apurinic/apyrimidinic (AP) sites are among the most frequent DNA lesions, arising thousands of times per cell each day. These lesions threaten genomic stability and, if left unrepaired, can lead to mutagenesis and disease. The base excision repair enzyme Apurinic/Apyrimidinic Endonuclease I (APE1) initiates repair by cleaving DNA at AP-sites, yet how APE1 efficiently identifies these lesions within vast excesses of undamaged DNA has remained unclear. Using single-molecule imaging, we show that APE1 employs a dynamic search strategy that integrates one-dimensional (1D) and three-dimensional (3D) diffusion to rapidly scan DNA. On non-damaged DNA, APE1 undergoes rapid diffusion, enabling efficient interrogation of large genomic regions within a single binding event. Upon encountering an AP-site, APE1 transitions from a mobile search state to a stable lesion-bound complex that remains localized at the site of damage. Experiments with APE1 variants further reveal that the intrinsically disordered N-terminal domain promotes 1D diffusion, residue R177 stabilizes APE1 at the AP-site after recognition, and catalytic residues D210 and E96 facilitate enzyme release following cleavage. Together, these findings define how APE1 balances rapid genome surveillance with stable lesion engagement and timely release. More broadly, this work provides a mechanistic framework for how DNA repair enzymes efficiently locate and process rare lesions embedded within excess undamaged DNA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Department of Cancer Biology, University of Kansas Medical Center, Kansas City, KS 66160, United States.
- Department of Biochemistry & Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22908, United States.
- Hillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15232, United States.
- Molecular Biophysics and Structural Biology Program, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, United States.
- University of Kansas Cancer Center, Kansas City, KS 66160, United States.
ORCID-Profile: Kaitlin M DeHart, Peyton N Oden, Tyler M Weaver, Bennett Van Houten, Bret D Freudenthal
Förderung
- NIEHS NIH HHS
- NIGMS NIH HHS
- NCI NIH HHS
- National Institute of Enviornmental Sciences
- National Institute of General Medical Sciences
- National Cancer Institute Cancer Center
Zitieren
APA
DeHart, K. M., Oden, P. N., Weaver, T. M., Schaich, M. A., Van Houten, B., & Freudenthal, B. D. (2026). A dynamic search mechanism enables APE1 to identify AP-sites in DNA. Nucleic Acids Research, 54(10). https://doi.org/10.1093/nar/gkag523
Vancouver
DeHart KM, Oden PN, Weaver TM, Schaich MA, Van Houten B, Freudenthal BD. A dynamic search mechanism enables APE1 to identify AP-sites in DNA. Nucleic Acids Research. 2026;54(10). doi:10.1093/nar/gkag523
BibTeX
@article{DeHart2026,
author = {DeHart, Kaitlin M and Oden, Peyton N and Weaver, Tyler M and Schaich, Matthew A and Van Houten, Bennett and Freudenthal, Bret D},
title = {A dynamic search mechanism enables APE1 to identify AP-sites in DNA},
journal = {Nucleic Acids Research},
year = {2026},
volume = {54},
number = {10},
doi = {10.1093/nar/gkag523}
}
EUVIMED